These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12846571)

  • 1. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP).
    Franklin MC; Kadkhodayan S; Ackerly H; Alexandru D; Distefano MD; Elliott LO; Flygare JA; Mausisa G; Okawa DC; Ong D; Vucic D; Deshayes K; Fairbrother WJ
    Biochemistry; 2003 Jul; 42(27):8223-31. PubMed ID: 12846571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
    Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
    Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
    Srinivasula SM; Hegde R; Saleh A; Datta P; Shiozaki E; Chai J; Lee RA; Robbins PD; Fernandes-Alnemri T; Shi Y; Alnemri ES
    Nature; 2001 Mar; 410(6824):112-6. PubMed ID: 11242052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
    Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
    Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
    J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of peptide-binding specificity of IAP BIR domains.
    Eckelman BP; Drag M; Snipas SJ; Salvesen GS
    Cell Death Differ; 2008 May; 15(5):920-8. PubMed ID: 18239672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library.
    Sweeney MC; Wang X; Park J; Liu Y; Pei D
    Biochemistry; 2006 Dec; 45(49):14740-8. PubMed ID: 17144666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
    Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
    J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of human survivin and its binding interface with Smac/Diablo.
    Sun C; Nettesheim D; Liu Z; Olejniczak ET
    Biochemistry; 2005 Jan; 44(1):11-7. PubMed ID: 15628841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).
    Vucic D; Deshayes K; Ackerly H; Pisabarro MT; Kadkhodayan S; Fairbrother WJ; Dixit VM
    J Biol Chem; 2002 Apr; 277(14):12275-9. PubMed ID: 11801603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway.
    Ma L; Huang Y; Song Z; Feng S; Tian X; Du W; Qiu X; Heese K; Wu M
    Cell Death Differ; 2006 Dec; 13(12):2079-88. PubMed ID: 16729033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists.
    Bornstein B; Gottfried Y; Edison N; Shekhtman A; Lev T; Glaser F; Larisch S
    Apoptosis; 2011 Sep; 16(9):869-81. PubMed ID: 21695558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
    Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
    Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
    Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
    Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
    Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases.
    Deveraux QL; Leo E; Stennicke HR; Welsh K; Salvesen GS; Reed JC
    EMBO J; 1999 Oct; 18(19):5242-51. PubMed ID: 10508158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.